St Jude Medical’s fighting talk in response to NEJM editorial suggesting its surveillance procedures are lacking and that Durata may suffer the same fate as its older brothers.
Implantable Defibrillators
New Research Suggests Sprint Fidelis Guidance Should Be Reviewed
Higher failure rates identified by researchers may indicate a policy of replacing Sprint Fidelis ICD units that haven’t malfunctioned.
Hackers Helping Defibrillator Patient Unlock “Unavailable” Implant Data
Hackers may be able to unlock data from implantable defibrillators.
Powering Pacemakers With Heartbeat Vibrations
Obvious innit? Researchers have proposed a technological solution which could provide energy for implantable devices such as pacemakers from the motion of the heart itself.
Just A Reminder: SJM Riata Is Subject To Alert In UK Too
Details of UK MHRA’s alert relating to St Jude’s Riata defibrillator leads.
Sparks Fly At Riata Lead Summit
A sizeable group of clinicians and St Jude representatives have met to discuss the issue of “externalised” Riata implantable defibrillator leads.
BIOTRONIK Commits To Asia Pacific With New Offices in Singapore
In common with other medical device manufacturers, BIOTRONIK clearly sees the growth opportunity in the Far East, announcing the opening of a new regional headquarters in Singapore.
St. Jude’s ASSERT Study Supports Implantable Device Monitoring To Identify Arrhythmia-Related Stroke Risk
Results from the St Jude sponsored ASSERT study has found that pacemaker patients who have no history of atrial tachycardia (AT) or AF, but do have device-detected arrhythmias, are approximately 2.5 times more likely to have a stroke than patients who do not have device-detected arrhythmias.
St Jude Launches Website Dedicated To Riata Silicone Lead Management
St. Jude Medical, Inc. has launched a Riata Lead Communication website to provide physicians with a compilation of important communications and updated information regarding the recent Riata® and Riata® ST Silicone Defibrillation Leads Class I recall.
St Jude Riata Voluntary Recall Judged By FDA as Class 1
12 months after European regulators issued alerts, St. Jude Medical, Inc. has now announced that following its voluntary medical device advisory letter to physicians from Nov. 28, 2011 the U.S. Food and Drug Administration (FDA) has now classified this action as a Class I Recall.
BIOTRONIK Introduces the World’s First and Only MRI Compatible Implantable Defibrillators
New MRI Compatible Lumax 740 series ICDs with ProMRI® offer extended longevity and BIOTRONIK Home Monitoring® for improved patient care.
More From AHA2011: Wearable Defibrillator Can Prevent Death In People With Arrhythmias
Heart rhythm records and calls about shocks from a registry of 14,475 patients with wearable defibrillators listed from 2007 through 2009 show 91.6 percent survived one or more episodes of ventricular fibrillation or ventricular tachycardia.
FIRST PATIENT ENROLLED IN SORIN IMPLANTABLE DEFIBRILLATOR STUDY
Study will evaluate the effectiveness of PARAD+™algorithm in minimizing inappropriate defibrillator shocks
Boston Scientific Corporation announces long-term data from the Prevention of Sudden Cardiac Death II registry (PreSCD II)
Boston Scientific Corporation’s PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors.
Sorin Group Announces European Market Release and First Implant of Its New-Generation Dual Chamber Implantable Cardioverter Defibrillator
Sorin Group announced today the commercial market release and first implant of its new generation PARADYM™ DR 8550 dual chamber implantable cardioverter-defibrillator (ICD).